HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nam Deuk Kim Selected Research

N1- hydroxy- N8- (4- phenoxyphenyl)octanediamide

8/2015MHY218-induced apoptotic cell death is enhanced by the inhibition of autophagy in AGS human gastric cancer cells.
1/2014A novel hydroxamic acid derivative, MHY218, induces apoptosis and cell cycle arrest through downregulation of NF-κB in HCT116 human colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nam Deuk Kim Research Topics

Disease

43Neoplasms (Cancer)
06/2022 - 02/2003
17Inflammation (Inflammations)
03/2022 - 04/2006
14Colonic Neoplasms (Colon Cancer)
09/2019 - 07/2004
12Leukemia
07/2013 - 06/2005
9Breast Neoplasms (Breast Cancer)
08/2017 - 02/2002
8Hepatocellular Carcinoma (Hepatoma)
05/2019 - 02/2003
7Carcinogenesis
07/2022 - 11/2013
7Prostatic Neoplasms (Prostate Cancer)
01/2019 - 09/2003
7Stomach Neoplasms (Stomach Cancer)
12/2018 - 12/2003
7Hypoxia (Hypoxemia)
08/2017 - 09/2008
6Carcinoma (Carcinomatosis)
03/2016 - 09/2003
5Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 03/2014
4Melanoma (Melanoma, Malignant)
01/2020 - 12/2004
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 04/2006
3Neoplasm Metastasis (Metastasis)
03/2016 - 09/2007
3Adenocarcinoma
06/2013 - 11/2009
2Macrocytic Anemia
04/2019 - 10/2015
2Congenital Abnormalities (Deformity)
04/2019 - 10/2015
2Cardiovascular Diseases (Cardiovascular Disease)
04/2019 - 10/2015
2Muscle Weakness
04/2019 - 10/2015
2Atrophy
01/2016 - 01/2014
2Muscular Atrophy (Muscle Atrophy)
09/2015 - 01/2014
2Insulin Resistance
12/2014 - 01/2014
2Colitis-Associated Neoplasms
09/2014 - 11/2013
2Cholestasis
02/2010 - 04/2006
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2008
9HS 1200IBA
10/2008 - 03/2003
9Chenodeoxycholic Acid (Chenix)FDA Link
10/2008 - 03/2003
7Bile Acids and Salts (Bile Acids)IBA
06/2022 - 09/2003
7CaspasesIBA
01/2022 - 12/2003
6Transcription Factors (Transcription Factor)IBA
09/2015 - 04/2006
5ApigeninIBA
03/2022 - 02/2003
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2014 - 06/2005
5HS-1199IBA
11/2005 - 09/2003
4Pharmaceutical PreparationsIBA
06/2022 - 05/2012
4ResveratrolIBA
08/2017 - 12/2013
44-(6-hydroxy-2-naphthyl)-1,3-benzenediolIBA
08/2017 - 12/2013
4Antineoplastic Agents (Antineoplastics)IBA
08/2017 - 04/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017 - 09/2008
4MHY-449IBA
11/2015 - 12/2012
4Caspase 3 (Caspase-3)IBA
01/2014 - 09/2005
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2009 - 09/2005
3Sirtuin 1IBA
07/2022 - 11/2020
3SirtuinsIBA
07/2022 - 11/2020
3AntioxidantsIBA
03/2022 - 01/2013
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022 - 09/2005
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2019 - 02/2009
3Oxygen (Dioxygen)IBA
08/2017 - 09/2008
3Therapeutic UsesIBA
08/2017 - 05/2012
3baicaleinIBA
03/2016 - 11/2013
3Ursolic AcidIBA
01/2016 - 03/2015
3LipidsIBA
08/2015 - 11/2005
3FlavonoidsIBA
05/2014 - 09/2008
3NF-kappa B (NF-kB)IBA
01/2014 - 11/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 04/2006
3dideoxypetrosynol AIBA
01/2007 - 12/2004
3Ursodeoxycholic Acid (Urso)FDA LinkGeneric
11/2005 - 09/2003
3HS 1183IBA
11/2005 - 09/2003
2CarcinogensIBA
06/2022 - 02/2002
2Histones (Histone)IBA
01/2022 - 06/2013
2Folic Acid (Vitamin M)FDA LinkGeneric
04/2019 - 10/2015
2HomocysteineIBA
04/2019 - 10/2015
2Biomarkers (Surrogate Marker)IBA
08/2017 - 04/2006
2Dexamethasone (Maxidex)FDA LinkGeneric
09/2015 - 01/2014
2N1- hydroxy- N8- (4- phenoxyphenyl)octanediamideIBA
08/2015 - 01/2014
2Hydroxamic Acids (Hydroxamic Acid)IBA
08/2015 - 01/2014
2TriterpenesIBA
03/2015 - 06/2008
2Betaine (C.B.B.)FDA Link
09/2014 - 09/2014
2AzoxymethaneIBA
09/2014 - 11/2013
2Dextran SulfateIBA
09/2014 - 11/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014 - 05/2012
2anthraceneIBA
01/2014 - 02/2002
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2014 - 01/2013
2fucoidanIBA
07/2013 - 08/2011
2Histone Deacetylase InhibitorsIBA
06/2013 - 10/2009
2Histone Deacetylases (Histone Deacetylase)IBA
06/2013 - 10/2009
26,7-dihydroxyflavoneIBA
03/2013 - 07/2012
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2012 - 04/2012
2LigandsIBA
11/2009 - 02/2008
2CollagenIBA
08/2009 - 04/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2008 - 06/2005
2Cytochromes c (Cytochrome c)IBA
02/2006 - 09/2005
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2022
1Anti-Allergic Agents (Antiallergic Agents)IBA
03/2022
1Antiviral Agents (Antivirals)IBA
03/2022
1Checkpoint Kinase 1IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1sirtinolIBA
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
01/2020
1Tumor Suppressor Protein p53IBA
09/2019
1Benzylidene CompoundsIBA
09/2019
1morinIBA
05/2019
1Auranofin (Ridaura)FDA Link
05/2019

Therapy/Procedure

10Therapeutics
01/2019 - 09/2003
6Chemoprevention
11/2020 - 01/2014
2Drug Therapy (Chemotherapy)
06/2013 - 06/2008
1Intravenous Injections
01/2020